Mkts

Editas Medicine, Inc.

NASDAQ: EDIT
$2.17+0.03 (+1.40%)
As of Nov 13, 9:30 AM ET

Key statistics

Day range
2.012.21
52-week range
1.663.94
Today
Open2.14
Previous close2.17
Volume2.79M
Valuation
Market cap334.92M
P/E ratio—
EPS (TTM)-0.74
Income & risk
Dividend / yield—
Beta2.19
Avg volume2.31M
Discussion

EDIT News

Stories mentioning EDIT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,83124,7417,5433,5784,65830,60561.00513.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development17,60027,40419,77516,18126,59348,61147,63954,210
Sales General & Admin
Total Operating Expenses27,83432,49632,09155,12280,82177,19765,72772,416
Operating Income (Loss)(25,003)(7,755)(24,548)(51,544)(76,163)(46,592)(65,666)(71,903)
Interest Income
Interest Expense
Other Expense(113.00)(5.00)(1.00)(1,758)(425.00)(3.00)(5.00)(1.00)
Pretax Income
Tax Provision
Net Income (Loss)(24,982)(5,620)(25,117)(53,235)(76,088)(45,395)(62,141)(67,607)
Earnings Per Share (Basic)(0.26)(0.06)(0.28)(0.63)(0.92)(0.55)(0.75)(0.82)
Earnings Per Share (Diluted)(0.26)(0.06)(0.28)(0.63)(0.92)(0.55)(0.75)(0.82)
Weighted Average Shares Outstanding (Basic)97,87988,74690,09084,41283,05582,33882,48582,310
Weighted Average Shares Outstanding (Diluted)97,87988,74690,09084,41283,05582,33882,48582,310

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About EDIT

Editas Medicine, Inc. (NASDAQ: EDIT) is a stock listed on the Nasdaq Stock Market under the ticker symbol EDIT. It last traded at $2.17 (Nov 13, 2026, 9:30 AM ET), up 1.4% on the day. That gives Editas Medicine a market capitalisation of $334.9M.

Over the past 52 weeks EDIT has traded between $1.66 and $3.94.

Revenue for the quarter ended Mar 31, 2026 was $2.8M; a net loss of $25.0M. Revenue was down 39.2% from $4.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.8M-$25.0M-882.4%
Dec 31, 2025$24.7M-$5.6M-22.7%
Sep 30, 2025$7.5M-$25.1M-333.0%
Jun 30, 2025$3.6M-$53.2M-1487.8%

From Editas Medicine’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…